Archives
ANNOUNCEMENT: Dr. Samuelson Makes History Implanting the First Commercial iStent Inject® in the U.S.
In late June, Glaukos (an ophthalmic medical technology company focused directly on the treatment of glaucoma) announced that the FDA had approved the much anticipated iStent inject® Trabecular Micro-Bypass System (or the iStent inject, for short) for patients with mild-to-moderate primary open-angle glaucoma. We are delighted to share that our very own Dr. Thomas W…. Read More
